Pamela J. Cramer Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

Pamela J. Cramer is Chief Human Resources Officer of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 13,500 shares of RYTM, which is worth approximately $662,850. The most recent transaction as insider was on Sep 09, 2024, when has been sold 4,099 shares (Common Stock) at a price of $50.03 per share, resulting in proceeds of $205,072. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.5K

57.46% 3M change

60.37% 12M change

Total Value Held $662,850

Pamela J. Cramer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 09 2024	SELL Open market or private sale	$205,072 $50.03 p/Share	4,099 Reduced 23.29%	13,500 Common Stock
Sep 09 2024	BUY Exercise of conversion of derivative security	$77,962 $19.02 p/Share	4,099 Added 18.89%	17,599 Common Stock
Aug 26 2024	SELL Open market or private sale	$160,032 $50.01 p/Share	3,200 Reduced 19.16%	13,500 Common Stock
Aug 26 2024	BUY Exercise of conversion of derivative security	$60,864 $19.02 p/Share	3,200 Added 16.08%	16,700 Common Stock
Aug 09 2024	SELL Open market or private sale	$2,223,892 $45.38 p/Share	49,006 Reduced 78.4%	13,500 Common Stock
Aug 09 2024	BUY Exercise of conversion of derivative security	$585,264 $19.02 p/Share	30,771 Added 32.99%	62,506 Common Stock
Jul 29 2024	SELL Open market or private sale	$68,438 $49.06 p/Share	1,395 Reduced 4.21%	31,735 Common Stock
Jul 26 2024	BUY Exercise of conversion of derivative security	-	3,125 Added 8.62%	33,130 Common Stock
Mar 19 2024	SELL Open market or private sale	$608,498 $39.22 p/Share	15,515 Reduced 34.08%	30,005 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	33,750 Added 42.58%	45,520 Common Stock
Feb 12 2024	SELL Open market or private sale	$35,760 $51.38 p/Share	696 Reduced 5.58%	11,770 Common Stock
Feb 09 2024	BUY Exercise of conversion of derivative security	-	2,344 Added 15.83%	12,466 Common Stock
Feb 01 2024	SELL Open market or private sale	$42,626 $45.06 p/Share	946 Reduced 8.55%	10,122 Common Stock
Feb 01 2024	BUY Exercise of conversion of derivative security	-	2,650 Added 19.32%	11,068 Common Stock
Jul 26 2023	SELL Open market or private sale	$16,405 $17.64 p/Share	930 Reduced 9.95%	8,418 Common Stock
Jul 26 2023	BUY Exercise of conversion of derivative security	-	3,125 Added 25.05%	9,348 Common Stock
Feb 09 2023	SELL Open market or private sale	$23,068 $27.66 p/Share	834 Reduced 11.94%	6,151 Common Stock
Feb 09 2023	BUY Exercise of conversion of derivative security	-	2,344 Added 25.13%	6,985 Common Stock
Aug 19 2022	SELL Open market or private sale	$335,031 $24.83 p/Share	13,493 Reduced 85.85%	2,224 Common Stock
Aug 19 2022	BUY Exercise of conversion of derivative security	$256,637 $19.02 p/Share	13,493 Added 46.19%	15,717 Common Stock
Jul 27 2022	SELL Open market or private sale	$10,524 $11.68 p/Share	901 Reduced 28.83%	2,224 Common Stock
Jul 26 2022	BUY Exercise of conversion of derivative security	-	3,125 Added 50.0%	3,125 Common Stock

PJC

Pamela J. Cramer

Chief Human Resources Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Value

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

Operation

Value

Type

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Track Activities on RYTM

Account